Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.
Library Archives
Volume 21, 2017 Archive

Six issues from 2017 in one convenient archive.

  • Full-color, full-text PDF files of articles and formulations from the Journal.
  • Print or save articles for your research, marketing, and educational needs.
  • Log-in to your account for keyword or topical search and download.
  • Purchased items appear with download icon in contents and search results.

Only $30000


(Select Format)
Instant Online Access

This archive contains the following articles listed by volume, issue and page number:

Issues Included
Issue/Volume Title
January/February 2017
Vol. 21 No. 1
Volume 21, Number 1
March/April 2017
Vol. 21 No. 2
Volume 21, Number 2
May/June 2017
Vol. 21 No. 3
Volume 21, Number 3
July/August 2017
Vol. 21 No. 4
Volume 21, Number 4
September/October 2017
Vol. 21 No. 5
Volume 21, Number 5
November/December 2017
Vol. 21 No. 6
Volume 21, Number 6

Volume 21, 2017 Articles
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
PreScription: Compounding Pharmacy Issues for 2017
Allen Loyd V Jr
Jan/Feb 2017
Pg. 4

Menopausal Symptom Relief and Side Effects Experienced by Women Using Compounded Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 3
Deleruyelle Laura J
Jan/Feb 2017
Pg. 6-16

When to Compound Medications for Veterinary Patients
Forsythe Lauren Eichstadt
Jan/Feb 2017
Pg. 19-21

Case Report: Diabetic Foot Ulcer Infection Treated with Topical Compounded Medications
Agbi Kelechi E
, Carvalho Maria, Phan Ha, Tuma Cristiane
Jan/Feb 2017
Pg. 22-27

Why You Should Become an International Academy of Compounding Pharmacists Member
Gates Ernest P Jr
Jan/Feb 2017
Pg. 28

Analytic Methods Used in Quality Control in a Compounding Pharmacy
Allen Loyd V Jr
Jan/Feb 2017
Pg. 31-37

Basics of Compounding with Dilutions and Concentrates
Allen Loyd V Jr
Jan/Feb 2017
Pg. 39-45

Basics of Sterile Compounding: Biopharmaceutics of Injectable Dosage Forms
Akers Michael J
Jan/Feb 2017
Pg. 47-56

Calculations
Stockton Shelly J
Jan/Feb 2017
Pg. 58-59

Clindamycin 10-mg/mL Oral Suspension
Allen Loyd V Jr
Jan/Feb 2017
Pg. 60

Diazoxide 10-mg/mL Oral Suspension
Allen Loyd V Jr
Jan/Feb 2017
Pg. 61

Infliximab 1% Ophthalmic Solution
Allen Loyd V Jr
Jan/Feb 2017
Pg. 62

Nifedipine 0.5% Rectal Ointment
Allen Loyd V Jr
Jan/Feb 2017
Pg. 63

Tetracaine Hydrochloride 0.5% Ophthalmic Solution
Allen Loyd V Jr
Jan/Feb 2017
Pg. 64

Zonisamide 10-mg/mL Oral Suspension
Allen Loyd V Jr
Jan/Feb 2017
Pg. 65

Compatibility and Stability of Rolapitant Injectable Emulsion Admixed with Dexamethasone Sodium Phosphate
Wu George
, Yeung Stanley, Chen Frank
Jan/Feb 2017
Pg. 66-75

Compatibility and Stability of Rolapitant Injectable Emulsion Admixed with Intravenous Palonosetron Hydrochloride
Wu George
, Yeung Stanley, Chen Frank
Jan/Feb 2017
Pg. 76-82

A Pilot Stability Study of Dehydroepiandrosterone Rapid-dissolving Tablets Prepared by Extemporaneous Compounding
Rush Steven D
, Vernak Charlene, Zhao Fang
Jan/Feb 2017
Pg. 83-87

PreScription: Whatever Happened to Common Sense?
Allen Loyd V Jr
Mar/Apr 2017
Pg. 92

U.S. Food and Drug Administration Inspections: Guide to a Successful Outcome for 503A Sterile Compounding Pharmacies
Yoch Doug
Mar/Apr 2017
Pg. 95-102

Restructuring the Art of Health by Pharmacists: Formulation Designs with Oral Vehicles--Teaching Pharmacy Students
Benischek Rita
Mar/Apr 2017
Pg. 105-108

Consultation for Human, Veterinary, and Compounded Medications
Moghadam Gabriella
, Forsythe Lauren Eichstadt
Mar/Apr 2017
Pg. 111-115

The International Academy of Compounding Pharmacists Introduces a New President
Rice Baylor
Mar/Apr 2017
Pg. 116-117

Quality Control: (Material) Safety Data Sheets
Allen Loyd V Jr
Mar/Apr 2017
Pg. 118-124

Basics of Compounding: 3D Printing--Pharmacy Applications, Part 1
Allen Loyd V Jr
Mar/Apr 2017
Pg. 127-130

Accuracy Considerations in Sterile Compounding
Akers Michael J
Mar/Apr 2017
Pg. 133-142

Calculations
Stockton Shelly J
Mar/Apr 2017
Pg. 144

Azathioprine 10-mg/mL Oral Suspension
Allen Loyd V Jr
Mar/Apr 2017
Pg. 146

Candesartan Cilexetil 8 mg Liquid-Filled Capsules
Allen Loyd V Jr
Mar/Apr 2017
Pg. 147

Furosemide 10-mg/mL Oral Suspension
Allen Loyd V Jr
Mar/Apr 2017
Pg. 148

Ketoconazole 20-mg/mL Oral Suspension
Allen Loyd V Jr
Mar/Apr 2017
Pg. 149

Stability of Alprostadil in 0.9% Sodium Chloride Stored in Polyvinyl Chloride Containers
McCluskey Susan V
, Kirkham Kylian, Munson Jessica M
Mar/Apr 2017
Pg. 150-153

Stability of Two Antifungal Agents, Fluconazole and Miconazole, Compounded in HUMCO RECURA Topical Cream to Determine Beyond-Use Date
Gautam Pradeep
, Light Bob, Purvis Troy
Mar/Apr 2017
Pg. 154-159

Stability of Extemporaneously Prepared Hydroxycarbamide Oral Suspensions
Kabiche Djamila
, Balde Issa-Bella, Majoul Elyes, Kabiche Sofiane, Bourguignon Elodie, Fontan Jean-Eudes, Cisternino Salvatore, Schlatter Joel
Mar/Apr 2017
Pg. 160-163

Development and Application of a High-Performance Liquid Chromatography Stability-Indicating Assay for Beyond-Use Date Determination of Compounded Topical Gels Containing Multiple Active Drugs
Gorman Gregory
, Sokom Simara, Coward Lori, Arnold John J
Mar/Apr 2017
Pg. 164-170

Suspensions as a Valuable Alternative to Extemporaneously Compounded Capsules
Dijkers Eli
, Nanhekhan Valerie, Thorissen Astrid, Polonini Hudson
Mar/Apr 2017
Pg. 171-175

PreScription: United States Pharmacopeia Chapter <800> Comments and Alternatives
Allen Loyd V Jr
May/Jun 2017
Pg. 180

Adventures in the Environmental World and Environmental Microbiology Sampling of Air for Pharmaceutical Sterile Compounding
Ligugnana Roberto
May/Jun 2017
Pg. 182-190

Microbiologic Testing for 503A Sterile-Compounding Pharmacies
Mixon William
, Roth Abby
May/Jun 2017
Pg. 193-203

Management of Psoriasis with a XemaTop Topical Compounded Formula: A Case Report
Jones Nat
, Carvalho Maria, Branvold-Herr Andrea
May/Jun 2017
Pg. 205-211

International Academy of Compounding Pharmacists Legislative/Regulatory Update
Rice Baylor
May/Jun 2017
Pg. 212-213

Basics of Compounding: 3D Printing--Pharmacy Applications, Part 2
Allen Loyd V Jr
May/Jun 2017
Pg. 215-220

Basics of Sterile Compounding: Manipulating Peptides and Proteins
Akers Michael J
May/Jun 2017
Pg. 223-228

Calculations
Stockton Shelly J
May/Jun 2017
Pg. 230-231

Candesartan Cilexetil 0.1-mg/mL to 2.0-mg/mL Oral Suspension
Allen Loyd V Jr
May/Jun 2017
Pg. 232

Ketoconazole 20-mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
May/Jun 2017
Pg. 233

Ketoprofen 10%, Baclofen 2%, Cyclobenzaprine Hydrochloride 2%, Lidocaine 2% in Lipopen Ultra Cream Base
Allen Loyd V Jr
May/Jun 2017
Pg. 234

Meloxicam 1% Topical Gel
Allen Loyd V Jr
May/Jun 2017
Pg. 235

Ofloxacin 0.3% Ophthalmic Solution
Allen Loyd V Jr
May/Jun 2017
Pg. 236

PVP Iodine 10% Antiseptic Cream
Allen Loyd V Jr
May/Jun 2017
Pg. 237

Tri-Est, Progesterone, and Testosterone in Versatile, Phytobase, Fitaline, and HRT Supreme Cream Bases
Allen Loyd V Jr
May/Jun 2017
Pg. 238

Trimethoprim 10-mg/mL Oral Suspension
Allen Loyd V Jr
May/Jun 2017
Pg. 239

Updated Stability Data for Midazolam, Oseltamivir Phosphate, and Propranolol Hydrochloride in SyrSpend SF and Minoxidil in Espumil
Dijkers Eli
, Nanhekhan Valerie, Thorissen Astrid
May/Jun 2017
Pg. 240-241

Absorption of Transdermal Fluoxetine Compounded in a Lipoderm Base Compared to Oral Fluoxetine in Client-owned Cats
Eichstadt Lauren R
, Corriveau Lorraine A, Moore George E, Knipp Gregory T, Cooper Bruce R, Gwin Wilson E
May/Jun 2017
Pg. 242-246

Warfarin Personalized Dosage: Re-compounding for a More Suitable Therapy and Better Compliance
Pellagatti Tommaso
, Ternelli Marco, Frascio Davide, Bettini Ruggero
May/Jun 2017
Pg. 247-250

Stability of Extemporaneously Prepared Hydroxychloroquine Sulfate 25-mg/mL Suspensions in Plastic Bottles and Syringes
McHenry Adam R
, Wempe Michael F, Rice Peter J
May/Jun 2017
Pg. 251-254

Stability of Alprazolam, Atropine Sulfate, Glutamine, Levofloxacin, Metoprolol Tartrate, Nitrofurantoin, Ondansetron Hydrochloride, Oxandrolone, Pregabaline, and Riboflavin in SyrSpend SF pH4 Oral Suspensions
de Oliveira Ferreira Anderson
, Polonini Hudson C, Loures da Silva Sharlene, Cerqueira de Melo Victor Augusto, de Andrade Laura, Fernandes Brandão Marcos Antônio
May/Jun 2017
Pg. 255-263

PreScription: Just Think About It!
Allen Loyd V Jr
Jul/Aug 2017
Pg. 268

Change Is In the Air: What You Need to Know About Pharmacy Ventilation Under United States Pharmacopeia <800>
Laniewicz Cheryl
Jul/Aug 2017
Pg. 271-274

Component Selection for Sterile Compounding
Dilzer Richard H
Jul/Aug 2017
Pg. 277-280

Simple Preparation of Timolol 0.5% Gel from Eye Drop Solution for Superficial Infantile Hemangiomas
Choo Winnie
Jul/Aug 2017
Pg. 282-289

The International Academy of Compounding Pharmacists Applauds the Leadership of Congressmen Griffith and Cuellar in Introducing Bill HR 2871
Rice Baylor
Jul/Aug 2017
Pg. 290-291

Basics of Compounding: 3D Printing: Pharmacy Applications, Part 3: Compounding, Formulation Considerations, and the Future
Allen Loyd V Jr
Jul/Aug 2017
Pg. 293-298

Basics of Sterile Compounding: Excipients Used in Injections
Akers Michael J
Jul/Aug 2017
Pg. 301-308

Calculations
Stockton Shelly J
Jul/Aug 2017
Pg. 310

Betamethasone 0.1% and Neomycin 0.6% Gel-Cream
Allen Loyd V Jr
Jul/Aug 2017
Pg. 312

Castor Oil 50% in Modified Pluronic Lecithin Organogel Gel
Allen Loyd V Jr
Jul/Aug 2017
Pg. 313

Copper Sulfate, Magnesium Sulfate, Phenylephrine, and Guaifenesin Pluronic Lecithin Organogel
Allen Loyd V Jr
Jul/Aug 2017
Pg. 314

Disopyramide 100-mg Capsules
Allen Loyd V Jr
Jul/Aug 2017
Pg. 315

Ferrous Sulfate 30-mg Fe/mL Oral Drops
Allen Loyd V Jr
Jul/Aug 2017
Pg. 316

Reteplase Injection
Allen Loyd V Jr
Jul/Aug 2017
Pg. 317

Sertraline Hydrochloride 10-mg/mL Oral Suspension
Allen Loyd V Jr
Jul/Aug 2017
Pg. 318

Tacrolimus 0.06% Ophthalmic Drops
Allen Loyd V Jr
Jul/Aug 2017
Pg. 319

Torsemide 10-mg/mL Injection
Allen Loyd V Jr
Jul/Aug 2017
Pg. 320

Tranilast 8% Pluronic Lecithin Organogel Gel
Allen Loyd V Jr
Jul/Aug 2017
Pg. 321

Physical and Chemical Stability of Budesonide Mucoadhesive Oral Suspensions (MucoLox)
Ip Kendice
, Carvalho Maria, Shan Ashley, Banov Daniel
Jul/Aug 2017
Pg. 322-329

Compounded Levofloxacin Triple Therapy is Safe and Effective for Refractory Helicobacter pylori
Mah Xian-Jun
, Gupta Vikas, Loch Srey Neth, Ahlenstiel Golo, van de Poorten David
Jul/Aug 2017
Pg. 330-333

Stability of Spironolactone Oral Suspension in PCCA Base, SuspendIt
Graves Richard
, Phan Kelly V, Bostanian Levon A, Mandal Tarun K, Pramar Yashoda V
Jul/Aug 2017
Pg. 334-338

Stability of Acetazolamide, Baclofen, Dipyridamole, Mebeverine Hydrochloride, Propylthiouracil, Quinidine Sulfate, and Topiramate Oral Suspensions in SyrSpend SF PH4
de Oliveira Ferreira Anderson
, Polonini Hudson, Loures da Silva Sharlene, Buzinari Aglio Natália Cristina, Abreu Jordana, Fernandes Brandão Marcos Antônio
Jul/Aug 2017
Pg. 339-346

Chemical Stability of Morphine, Ropivacaine, and Ziconotide in Combination for Intrathecal Analgesia
Robert Julien
, Sorrieul Jérémy, Rossignol Elsa, Beaussart Hélène, Kieffer Hélène, Folliard Caroline, Dupoiron Denis, Devys Catherine
Jul/Aug 2017
Pg. 347-351

PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs
Allen Loyd V Jr
Sep/Oct 2017
Pg. 356

Compounding Opportunities in Urology
Biundo Bruce
Sep/Oct 2017
Pg. 358-362

Child-safety Containers/Devices and Compounding
Allen Loyd V Jr
Sep/Oct 2017
Pg. 364-370

Documentation: Records and Reports
Akers Michael J
Sep/Oct 2017
Pg. 373-380

IACP Legislative/Regulatory Update
International Academy of Compounding Pharmacists
Sep/Oct 2017
Pg. 382-383

Quality Control: Bar Codes and Bar Code Scanners for Unit-Dose Medications in a Healthcare Setting
Medi-Dose Inc./EPS Inc.
Sep/Oct 2017
Pg. 384-387

Basics of Compounding: 3D Printing--Pharmacy Applications: Geometric Shape Effects on 3D Printing
Allen Loyd V Jr
Sep/Oct 2017
Pg. 388-392

Basics of Sterile Compounding: Particulate Matter
Akers Michael J
Sep/Oct 2017
Pg. 395-404

Calculations
Stockton Shelly J
Sep/Oct 2017
Pg. 406

Acetylcysteine Solutions for Inhalation
Allen Loyd V Jr
Sep/Oct 2017
Pg. 408

Carbamazepine 25-mg/mL in SyrSPend SF pH4 Oral Suspension
Allen Loyd V Jr
Sep/Oct 2017
Pg. 409

Etoposide 20-mg/mL Injection
Allen Loyd V Jr
Sep/Oct 2017
Pg. 410

Fentanyl Citrate 50-mcg/mL Injection
Allen Loyd V Jr
Sep/Oct 2017
Pg. 411

Fluoxymesterone 10-mg Capsules
Allen Loyd V Jr
Sep/Oct 2017
Pg. 412

Ioversol Injection
Allen Loyd V Jr
Sep/Oct 2017
Pg. 413

Levocarnitine 100-mg/mL Oral Solution
Allen Loyd V Jr
Sep/Oct 2017
Pg. 414

Peritoneal Dialysis Solution with 1.5%, 2.5%, or 4.25% Dextrose
Allen Loyd V Jr
Sep/Oct 2017
Pg. 415

Tacrolimus 0.3-mg/mL Ophthalmic Solution
Allen Loyd V Jr
Sep/Oct 2017
Pg. 416

Vancomycin 50 mg/mL in Oral Syrup Suspension
Allen Loyd V Jr
Sep/Oct 2017
Pg. 417

Kinetic Analysis of Drug Release from Compounded Slow-release Capsules of Liothyronine Sodium (T3)
Bakhteyar Hamid
, Cassone Clayton, Kohan Hamed Gilzad, Sani Shabnam N
Sep/Oct 2017
Pg. 418-425

Stability of Dalteparin 1,000 Unit/mL in 0.9% Sodium Chloride for Injection in Polypropylene Syringes
Kirkham Kylian
, Munson Jessica M, McCluskey Susan V, Graner Kevin K
Sep/Oct 2017
Pg. 426-429

Physicochemical Stability of an Oral Suspension of Trimethoprim 20 mg/mL in Combination with Sulfadiazine 200 mg/mL in PCCA Base SuspendIt
Graves Richard A
, Phan Kelly V, Bostanian Levon A, Mandal Tarun K, Pramar Yashoda V
Sep/Oct 2017
Pg. 430-435

Stability of Dexmedetomidine in 0.9% Sodium Chloride in Two Types of Intravenous Infusion Bags
Marquis Kathleen
, Hohlfelder Benjamin, Szumita Paul M
Sep/Oct 2017
Pg. 436-439

PreScription: Issues with the NAMS 2017 Hormone Therapy Position Statement
Allen Loyd V Jr
Nov/Dec 2017
Pg. 444

Feline Transdermal Formulation Considerations
Forsythe Lauren Eichstadt
Nov/Dec 2017
Pg. 446-452

Orodispersible Films for Compounding Pharmacies
Ferreira Anderson O
, Brandão Marcos Antônio F, Raposo Francisco José, Polonini Hudson C, Raposo Nádia Rezende Barbosa
Nov/Dec 2017
Pg. 454-461

Features of Pharmaceutical Compounding in the Republic of Tajikistan
Alfred-Ugbenbo DS
, Valiev AH, Zdoryk OA, Georgiyants VA
Nov/Dec 2017
Pg. 463-467

Join the Partnership for Personalized Prescriptions (P3) Advocacy Effort!
Blankenship Cynthia
Nov/Dec 2017
Pg. 468

Basics of Compounding: Hot Melt Extrusion
DePasquale Seth
Nov/Dec 2017
Pg. 471-479

Basics of Compounding: Compounding Irrigation Solutions for Sterile and Nonsterile Preparations
Allen Loyd V Jr
Nov/Dec 2017
Pg. 481-486

Calculations
Stockton Shelly J
Nov/Dec 2017
Pg. 488

Amitriptyline 20 mg/mL in OraPlus:OraSweet Suspension
Allen Loyd V Jr
Nov/Dec 2017
Pg. 490

Dapsone 2 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
Nov/Dec 2017
Pg. 491

Fluconazole 10% in RECURA Cream
Allen Loyd V Jr
Nov/Dec 2017
Pg. 492

Haloperidol 5-mg/mL Injection
Allen Loyd V Jr
Nov/Dec 2017
Pg. 493

Hydroxychloroquine Sulfate 25 mg/mL in Oral Mix or Oral Mix SF
Allen Loyd V Jr
Nov/Dec 2017
Pg. 494

Promethazine Hydrochloride 12.5 mg/0.1 mL in PLO Gel
Allen Loyd V Jr
Nov/Dec 2017
Pg. 495

Spironolactone 5 mg/mL in SuspendIt Oral Suspension
Allen Loyd V Jr
Nov/Dec 2017
Pg. 496

Tolmetin 400-mg Capsules
Allen Loyd V Jr
Nov/Dec 2017
Pg. 497

Trace Elements Injection 5
Allen Loyd V Jr
Nov/Dec 2017
Pg. 498

Vancomycin 5-mg/mL Injection
Allen Loyd V Jr
Nov/Dec 2017
Pg. 499

To Flavor or Not to Flavor Extemporaneous Omeprazole Liquid
Chuong Monica C
, Taglieri Catherine A, Kerr Stephen G
Nov/Dec 2017
Pg. 500-512

Validation of the Technological Process of the Preparation "Milk by Vidal"
Savchenko LP
, Mishchenko VA, Georgiyants VA
Nov/Dec 2017
Pg. 513-517

Auditing Safety of Compounding and Reconstituting of Intravenous Medicines on Hospital Wards in Finland
Suvikas-Peltonen Eeva
, Palmgren Joni, Häggman Verner, Celikkayalar Ercan, Manninen Raija, Airaksinen Marja
Nov/Dec 2017
Pg. 518-529

Effect of Penetration Enhancers on the Percuaneous Delivery of Hormone Replacement Actives
Trimble John O
, Light Bob
Nov/Dec 2017
Pg. 530-535

Return to Top